James Christopher Barry - Feb 10, 2022 Form 4 Insider Report for NUVASIVE INC (NUVA)

Role: Chief Executive Officer, Director
Signature: /s/ Nathaniel B. Sisitsky, Attorney-in-fact for James Christopher Barry
Stock symbol: NUVA
Transactions as of: Feb 10, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/14/2022, 04:47 PM
Previous filing: Nov 9, 2021
Next filing: Mar 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUVA	PRSUs	Award	$0	+19.3K		$0.00	19.3K	Feb 10, 2022	Common Stock	19.3K	$0.00	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting.
F2	This PRSU award was granted to the Reporting Person on March 1, 2019. The award was granted based on a target number of shares with a performance multiplier of 0-200% based on the Issuer's non-GAAP Operating Margin over the performance period ended December 31, 2021. On February 10, 2022, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 19,323 shares on March 1, 2022, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant.

Content

Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting.

This PRSU award was granted to the Reporting Person on March 1, 2019. The award was granted based on a target number of shares with a performance multiplier of 0-200% based on the Issuer's non-GAAP Operating Margin over the performance period ended December 31, 2021. On February 10, 2022, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 19,323 shares on March 1, 2022, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant.